Dissemin is shutting down on January 1st, 2025

Published in

Nature Research, Scientific Reports, 1(11), 2021

DOI: 10.1038/s41598-021-84070-7

Links

Tools

Export citation

Search in Google Scholar

The influence of human genetic variation on Epstein-Barr virus sequence diversity

Journal article published in 2020 by Begoña Martinez de Tejada, Evgeny Zdobnov ORCID, Marcel Stöckle, Philip Tarr ORCID, Alexandra Trkola, Pietro Vernazza, Noémie Wagner, Gilles Wandeler, Rainer Weber, Sabine Yerly, Sina Rueeger, Sina Rüeger, Karoline Aebi-Popp, Alexia Anagnostopoulos, Christian Hammer and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

AbstractEpstein–Barr virus (EBV) is one of the most common viruses latently infecting humans. Little is known about the impact of human genetic variation on the large inter-individual differences observed in response to EBV infection. To search for a potential imprint of host genomic variation on the EBV sequence, we jointly analyzed paired viral and human genomic data from 268 HIV-coinfected individuals with CD4 + T cell count < 200/mm3 and elevated EBV viremia. We hypothesized that the reactivated virus circulating in these patients could carry sequence variants acquired during primary EBV infection, thereby providing a snapshot of early adaptation to the pressure exerted on EBV by the individual immune response. We searched for associations between host and pathogen genetic variants, taking into account human and EBV population structure. Our analyses revealed significant associations between human and EBV sequence variation. Three polymorphic regions in the human genome were found to be associated with EBV variation: one at the amino acid level (BRLF1:p.Lys316Glu); and two at the gene level (burden testing of rare variants in BALF5 and BBRF1). Our findings confirm that jointly analyzing host and pathogen genomes can identify sites of genomic interactions, which could help dissect pathogenic mechanisms and suggest new therapeutic avenues.